| CAT No: | CL-ASTR-NO-02 |
| CAS No: | NA |
| Mol.F: | C16H15N5O2 |
| Mol.Wt.: | 309.32 |
| Chemical Name: | 5-methyl-2-((5-methyl-1-nitroso-1H-imidazol-4-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one |
| Inventory Status: | Justification |
This impurity is related to N-Nitroso Alosetron is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso Alosetron is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:5-methyl-2-((5-methyl-1-nitroso-1H-imidazol-4-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-oneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Alosetron Molecular Formula: C16H15N5O2
Molecular Weight: 309.32
Storage: Store in a cool, dry place.
| Product Name: | N-Nitroso Alosetron |
| CAS No: | |
| Mol.F.: | C16H15N5O2 |
| Mol.Wt.: | 309.32 |
Cat. No: Cl-ASTR-01
CAS No: 122852-42-0
Mol. F: C17H18N4O
Mol. Wt: 294.4
Inv. Status: Custom Synthesis
Cat. No: Cl-ASTR-02
CAS No: 128486-89-5
Mol. F: C17H18N4O2
Mol. Wt: 310.4
Inv. Status: Custom Synthesis
Cat. No: Cl-ASTR-03
CAS No: 2518312-31-5
Mol. F: C13H14N2O
Mol. Wt: 214.3
Inv. Status: Custom Synthesis
Cat. No: Cl-ASTR-04
CAS No: 122852-75-9
Mol. F: C12H12N2O
Mol. Wt: 200.2
Inv. Status: Custom Synthesis
Cat. No: CL-ASTR-NO-01
CAS No: NA
Mol. F: C16H15N5O2
Mol. Wt: 309.33
Inv. Status: Justification
Cat. No: CL-ASTR-NO-03
CAS No: NA
Mol. F: C12H11N3O2
Mol. Wt: 229.24
Inv. Status: Custom Synthesis
Cat. No: CL-ASTR-NO-04
CAS No: NA
Mol. F: C11H9N3O2
Mol. Wt: 215.21
Inv. Status: Custom Synthesis
Cat. No: CL-ASTR-NO-05
CAS No: NA
Mol. F: C17H17N5O3
Mol. Wt: 339.36
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: